Many marine bacteria secrete exopolysaccharides (EPSs), which are made up of a substantial component of the macro-molecules surrounding cells. Recently, the wide demand for EPSs for food, cosmetics, pharmaceutical and other applications has led to great interest in them. In this study, an EPS produced by marine bacteria Aerococcus uriaeequi HZ strains (EPS-A) was isolated and purified to examine its structure and biological function. The molecular weight of EPS-A analyzed by high-performance liquid gel filtration chromatography (HPGFC) is found to have a number average of 2.22 × 10⁵ and weight average of 2.84 × 10⁵, respectively. High-performance liquid chromatography (HPLC) and Fourier-transform–infrared (FT–IR) analysis indicate that EPS-A was a polysaccharide composed of glucose and a little mannose. In addition, the flocculating rate of sewage of EPS-A was 79.90%. The hygroscopicity studies showed that hygroscopicity of EPS-A was higher than chitosan but lower than that of sodium hyaluronate. The moisture retention of EPS-A showed similar retention activity to both chitosan and sodium hyaluronate. EPS-A also can scavenge free radicals including both OH• free radical and O₂•⁻ free radical and the activity to O₂•⁻ free radical is similar to vitamin C. Safety assessment on mice indicated that the EPS-A is safe for external use and oral administration. EPS-A has great potential for applications in medicine due to its characteristics mentioned above.

• Intestinal microbiota has been increasingly studied in the field of IBD over the last 20 years. • The gut microbiome, metabolites, and their corresponding host signaling pathways are highly associated with IBD. • Probiotics may relieve IBD as a complementary therapy. • The pathogenesis and treatment strategies of IBD need to be further studied.

Aflatoxin B1 (AFB1) is a hepatotoxic fungal metabolite that is widely present in food and can cause liver cancer. As a potential detoxifier, naturally occurring humic acids (HAs) may be able to reduce inflammation and restructure the gut microbiota composition; however, little is known about the mechanism of HAs detoxification as applied to liver cells. In this study, HAs treatment alleviated AFB1-induced liver cell swelling and the infiltration of inflammatory cells. HAs treatment also reinstated various enzyme levels in the liver disturbed by AFB1 and substantially alleviated AFB1-caused oxidative stress and inflammatory responses by enhancing immune functions in mice. Moreover, HAs increased the length of the small intestinal and villus height to restore intestinal permeability, which is impaired by AFB1. In addition, HAs reconstructed the gut microbiota, increasing the relative abundance of Desulfovibrio, Odoribacter, and Alistipes. In vitro and in vivo assays demonstrated that HAs could efficiently remove AFB1 by absorbing the toxin. Therefore, HAs treatment can ameliorate AFB1-induced hepatic injury by enhancing gut barrier function, regulating gut microbiota, and adsorbing toxin.

Humic acids (HAs) are natural polymers with diverse functional groups that have been documented and utilized in traditional Chinese medicine. Dextran sulfate sodium (DSS)-induced colitis has been used as a model to study inflammatory bowel disease. In this research, we investigate the effect of HAs on ameliorating DSS-induced colitis in mice. Our aim here was to investigate if HAs could be a remedy against colitis and the mechanisms involved. The results show that HAs facilitated a regain of body weight and restoration of intestinal morphology after DSS-induced colitis. HAs treatment alters the community of gut microbiota with more Lactobacillus and Bifidobacterium. Changes in bacterial community result in lower amounts of lipopolysaccharides in mouse sera, as well as lower levels of inflammatory cytokines through the Toll-like receptor 4 (TLR4)-NF-κB pathway. HAs also promoted the expression of tight junction proteins, which protect the intestinal barrier from DSS damage. Cell experiments show that HAs display an inhibitory effect on DSS growth as well. These results suggest that HAs can alleviate colitis by regulating intestinal microbiota, reducing inflammation, maintaining mucosal barriers, and inhibiting pathogen growth. Thus, HAs offer great potential for the prevention and treatment of colitis.

Prodigiosin is a red pigment produced by Serratia marcescens with anticancer, antimalarial, and antibacterial effects. In this study, we extracted and identified a red pigment from a culture of S. marcescens strain ZPG19 and investigated its effect on the growth performance and intestinal microbiota of Kunming mice. High-performance liquid chromatography/mass spectrometry revealed that the pigment had a mass-to-charge ratio (m/z) of 324.2160, and thus it was identified as prodigiosin. To investigate the effect of prodigiosin on the intestinal microbiota, mice (n = 5) were administered 150 μg/kg/d prodigiosin (crude extract, 95% purity) via the drinking water for 18 days. Administration of prodigiosin did not cause toxicity in mice. High-throughput sequencing analysis revealed that prodigiosin altered the cecum microbiota abundance and diversity; the relative abundance of Desulfovibrio significantly decreased, whereas Lactobacillus reuteri significantly increased. This finding indicates that oral administration of prodigiosin has a beneficial effect on the intestinal microbiota of mice. As prodigiosin is non-toxic to mouse internal organs and improves the mouse intestinal microbiota, we suggest that it is a promising candidate drug to treat intestinal inflammation.